16.1% on semaglutide Tirzepatide was superior on all five key secondary endpoints Gastrointestinal discontinuation rate was lower with tirzepatide (2.7%) than semaglutide (5.6%) These findings were consistent across all patient subgroups, regardless of sex, age, baseline BMI, or presence of metabolic comorbidities
It's been perfect for my long workouts
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinsons disease: an open label, phase I trial
In summary, MS/MS mapping demonstrates that aza-substitution at the DPP-4 hotspot provides robust protection against N-terminal degradation, with proteolytic breakdown converging on shared internal sites across the different analogues
The other 34 patients, who all received the intended treatment and were analyzed, were predominantly female (67.6%) and had a median (IQR) age of 29.5 years (26.0, 38.8)
Everyone at Genesis has been fantastic to work with